Pharmaceutical manufacturers of Selexipag

MEGAFINE provides cutting-edge and comprehensive API solutions and is inspected by regulatory authorities including USFDA, EU-GMP, Australia-TGA, Canada-HC, Korea-MFDS, Japan-PMDA, and Mexico-COFEPRIS. This esteemed manufacturer specializes in high-quality APIs and Intermediates, serving both Innovators and Generic companies. With an impressive track record of 26 US-DMFs, 6 CEPs, and over 250 global regulatory filings, MEGAFINE has recently inaugurated a state-of-the-art API plant to meet its growing demand and expansion.

Honour Lab Limited is based in India. The corporation's primary activity involves the production, crafting, or refinement of medications in pharmaceutical formulations for human or animal application.

Nuray Chemicals Pvt Ltd is a manufacturing facility approved by the US Food and Drug Administration (USFDA) for active pharmaceutical ingredients (API) with an advanced research and development/manufacturing site situated in Thiruvallur, near Chennai, in the state of Tamil Nadu, India. Nuray has extensive experience in launching products in the pharmaceutical industry, particularly in developing niche, novel, and challenging-to-produce APIs for commercial use, meeting chemistry requirements through synthesis.

Maithri Drugs stands as one of the rapidly emerging pharmaceutical firms in India. Maithri's primary emphasis is on active pharmaceutical ingredients (APIs). The corporation is widely acknowledged for its exceptional research & development and ambitious expansion approaches. Our 125+Global DMFs, including 50 in the United States and 22 in the EU within a brief duration, bear witness to our R&D superiority. Maithri's production site is situated in Hyderabad. This site is scrutinized and endorsed by the US FDA. Furthermore, our facility is accredited in accordance with the criteria of DCGI, WHO GMP, and ISO 9001.

RK Pharma Inc operates as a privately owned company in the United States. Our primary focus is on the production and distribution of cost-effective generic pharmaceutical products globally. With an emphasis on products facing formulation challenges and initial generic opportunities, we have successfully integrated development, regulatory, and manufacturing capabilities. Our advanced facility in Pearl River, New York specializes in overseeing the streamlined process of bulk manufacturing and multi-format packaging, as well as conducting end-product release testing tailored for injectables, sterile ophthalmic, and dermal products.

Maithili Life Sciences offers services including DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, and News related to GMP.